PrEP-001 + G-004

Phase 2Completed
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Dec 11, 2015 → Sep 1, 2016

About PrEP-001 + G-004

PrEP-001 + G-004 is a phase 2 stage product being developed by hVIVO for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT03296917. Target conditions include Asthma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03296917Phase 2Completed